EUFLEXXA
FDA premarket approval P010029/S027 · decided 2018-11-19
Approval details
- PMA number
- P010029
- Supplement
- S027
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- EUFLEXXA
- Generic name
- Acid, hyaluronic, intraarticular
- Applicant
- Ferring Pharmaceuticals, Inc.
- Date received
- 2018-08-22
- Decision date
- 2018-11-19
- Days to decision
- 89 days
- Decision code
- APPR
- Product code
- MOZ
- Advisory committee
- Orthopedic
- Expedited review
- No
- Location
- Parsippany, NJ
- Statement
- Approval for a minor design and material change to the tip cap of the syringe utilized to inject EUFLEXXA.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.